Shares of Health Care sector company Amgen moved 1.4% today, and are now trading at a price of $294.45. The Large-Cap stock's daily volume was 271,833 compared to its average volume of 3,086,278. The S&P 500 index returned a -0.0% performance.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company is based in Thousand Oaks and has 28,000 full time employees. Its market capitalization is $158,327,537,664. Amgen currently offers its equity investors a dividend that yields 3.1% per year.
28 analysts are following Amgen and have set target prices ranging from $185.0 to $400.0 per share. On average, they have given the company a rating of buy. At today's prices, AMGN is trading -6.31% away from its average analyst target price of $314.27 per share.
Over the last year, AMGN shares have gone down by -6.1%, which represents a difference of -18.0% when compared to the S&P 500. The stock's 52 week high is $346.85 per share and its 52 week low is $253.3. With average free cash flows of $8.89 Billion that have been growing at an average rate of 2.4% over the last 5 years, Amgen declining stock performance may not be reflective of the quality of its underlying business.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 11,490,000 | 1,096,000 | 10,394,000 | 41.24 |
| 2023 | 8,471,000 | 1,112,000 | 7,359,000 | -16.23 |
| 2022 | 9,721,000 | 936,000 | 8,785,000 | 4.82 |
| 2021 | 9,261,000 | 880,000 | 8,381,000 | -15.25 |
| 2020 | 10,497,000 | 608,000 | 9,889,000 | 15.9 |
| 2019 | 9,150,000 | 618,000 | 8,532,000 |
